TAKE ACTION

Require train operators keep ticket offices and platform staff at train stations

We want the Government to require train operators keep ticket offices and platform staff at train stations, to help maintain health and safety standards and customer information.

Sign the petition
👇
https://petition.parliament.uk/petitions/636542

A surprising article in the WSJ, demonstrating that those who government & the spooks censored were right. Censorship is purely to protect those in power. They lie when they claim it’s to protect you from “misinformation”.
Best wishes
Mike

https://archive.li/2023.07.07-221936/https://www.wsj.com/amp/articles/covid-censorship-proved-to-be-deadly-social-media-government-pandemic-health-697c32c4

The ULEZ is a tax on the poor.
Sadiq Khan needs to be gone.
https://www.youtube.com/watch?v=ePG3iDdgQBg

The Energy Bill is an attack on freedom and home ownership
https://www.youtube.com/watch?v=_gZg9BwFe2I

TODAY: ULEZ protest 11am, Parliament Square, London SW1P

ULEZ an undemocratic attack & tax on our mobility

As are "Low Traffic Neighbourhoods", "Clean Air Zones" etc around UK

Pls support & share

Lahaina Ohana
https://youtube.com/watch?v=LiKCeCUMahs&feature=shared

Where’s Oprah’s $10 million donation coming from? (1 minute, 13 seconds)

The Guardian has reached out to me for comment on the "heat wave" with regards to my previous comments on temperatures in Italy. Gave me a window of 4 hours to reply. I did. Watch this space.. 😎☀️😁

@RobinMG

P.S. Of course it's a trap, I have a copy of my email reply I will publish if they misrepresent me completely.

A well argued opinion, in my opinion, that Drag Queen Story Hour doesn’t belong in primary school.
Best wishes
Mike

https://www.hartgroup.org/drag-queen-story-hour/

UNIVERSAL DECLARATION OF BIOETHICS & HUMAN RIGHTS, UNESCO, 2005.

Article 16
Protecting future generations
The impact of life sciences on future generations, including on their genetic constitution, should be given due regard.

https://twitter.com/robinmonotti/status/1699408914817630234

THE US BIOWARFARE PROJECT WHICH CAUSED THE COVID-19 DEBACLE – PART 7 - Paula Jardine
https://www.conservativewoman.co.uk/the-us-biowarfare-project-which-caused-the-covid-19-debacle-part-7/

"On October 17, 2014, the US government took action, ordered a review and grounded its biodefence programme by imposing a moratorium on research which ‘could be reasonably anticipated to confer attributes to influenza, MERS, or SARS viruses such that the resulting virus has enhanced pathogenicity and/or transmissibility (via the respiratory route) in mammals’.

This had immediate impacton the University of North Carolina Chapel Hill (UNC-CH) where, under the supervision of Dr Ralph Baric, most of the SARS and MERS gain-of-function research was conducted. The paper published under his and other names in 2015 arguing that‘a SARS-like cluster of circulating bat coronaviruses shows potential for human emergence’ was presumably based on research conducted before the moratorium. Its funding had come from the USAID PREDICT programme via the EcoHealth Alliance whose website home page promotes pandemic fear porn: ‘Who stands between you and the next pandemic?’ The 2015 paper compared the potential of SARS, MERS and a bat coronavirus sample held by the Wuhan Institute of Virology (WIV) called WIV1 to cause an epidemic disease in humans and evaluated the potential of vaccines and monoclonal antibodies as countermeasures. Shi Zhengli, the WIV researcher who is known as the ‘bat lady’, provided the UNC-CH researchers with the genetic sequence for WIV1 and is a co-author on the paper. Baric was later to write the gain-of-function section of the notorious EcoHealth Alliance 2018 funding proposal DEFUSE to make an aerosolised coronavirus vaccine for bats, which was rejected by the US Defense Advanced Research Projects Agency DARPA.

DARPA officer Major Joseph Murphy, who reviewed the files on the DEFUSE proposal, concluded in an August 2021 memo that ‘SARS-CoV-2 is an American-created recombinant bat vaccine or its precursor virus’ (my italics). He wrote ‘Americans are creative, if imprudent, and technologically confident enough to try it,’ and blamed the National Institutes of Health (NIH) and Dr Anthony Fauci directly. Murphy said the mRNA vaccines ‘work poorly because they are synthetic replications of the already-synthetic SARS-CoV-WIV spike proteins’. His concluding paragraph reads: ‘The massive, “Manhattan Project”-level suppression of information by the government and the Trusted News Initiative indicates that it would be covered up if something bad happened.’ The Trusted News Initiative was founded by the UK’s very own Ministry of Truth, the BBC. DARPA has confirmed to Trialsite News that Murphy’s memo was genuine (personal communication).

The intent of the moratorium was to pause ‘research that improves the ability of a pathogen to cause disease’; pathogenicity and transmissibility studies of both SARS and MERS coronaviruses, of which MERS was considered to be the more dangerous, were grounded. Clinical trials in humans of coronavirus vaccines which had previously been found to cause pathological changes in the lungs and enhance respiratory disease were also paused. A throwaway sentence in a report published by CEPI, the Coalition for Epidemic Preparedness Innovations, ‘Since concerns over SARS-related pathology led to a US Food and Drug Administration (FDA) clinical hold on [coronavirus] vaccine studies [in people], investigation of MERS-CoV vaccine candidates to induce virus-enhancing antibodies and harmful immune response in [pre-clinical] animal models could be informative before human clinical trials are initiated’, reveals a determination to carry on with MERS animal studies in anticipation of clinical trials being permitted in future. MERS was on the DARPA priority list for vaccine development but SARS wasn’t.

"The biodefence renegades soldiered on undercover with their mission to develop coronavirus vaccines. This explains the secrecy associated with Moderna’s mRNA-MERS coronavirus vaccine project. (As of June 2023, there have been only 2,605 PCR test-confirmed MERS cases). It made little commercial sense for the fledgling company with no licensed products to be developing a vaccine with a limited commercial market while there was a moratorium on trials. However Moderna’s August 2022 patent infringement lawsuit against Pfizer reveals that Moderna’s infectious disease division began developing a MERS vaccine in 2015 for Merck (the company is known as MSD outside North America) which had entered into a joint venture with Moderna to develop mRNA vaccines against infectious diseases. Moderna was leveraging Merck’s reputation and credibility as a long-established vaccine developer and manufacturer in bringing Moderna’s mRNA vaccines to market under this joint venture. The original intention was for Merck exclusively to commercialise them for Moderna.

In January 2016, during the FDA’s moratorium on clinical trials, Stephane Bancel, Moderna’s CEO, sought an amendment to the Merck Master Collaboration Agreement (MCA). Merck agreed to substitute VZV (varicella zoster virus which causes shingles) for a substance which is redacted in the paperwork. Whether this was related to the unexpected resignation of Moderna’s Chief Scientific Officer, Joseph Bolen, in charge of the product development pipeline, for undisclosed reasons a few months before, we don’t know. Six months later Merck sought and obtained another amendment allowing it to do due diligence on Moderna’s mRNA vaccines by nominating new candidates and running the trials themselves, instead of paying Moderna to do it for them.

In October 2016, Moderna started building a 200,000 sq ft factory in Norwood, Massachusetts.

At its stock market debut in December 2018 Moderna said it was developing two vaccine candidates for Merck, mRNA-1278 (which it claims was a shingles vaccine) and mRNA-1777, a vaccine for respiratory syncytial virus (RSV). (The first attempt to develop RSV vaccines in the 1960s had been disastrous and none was ever successfully licensed. The children vaccinated in the clinical trials suffered from enhanced respiratory disease and many died. The same problem of vaccine-enhanced disease was later found in animal trials of SARS and MERS vaccines.)

The RSV vaccine developed by Moderna for Merck used a stabilised protein design developed by Dr Barney Graham of the US NIAID Vaccine Research Centre. Graham believed it solved the vaccine-enhanced disease problem, and the same design approach was used in all the Operation Warp Speed financed Covid-19 vaccines. The RSV vaccine mRNA-1777 went into clinical trials in Australia at the start of 2018. In effect it was a forerunner of the MERS candidate (and ultimately the SARS-CoV-2 vaccine) enabling Moderna to test the design and dosing in humans. Moderna’s December 2018 prospectus for its stock market launch stated: ‘Merck has initiated plans for a Phase 2a trial, for which Merck will be the sponsor. In addition, we are working with Merck to identify and advance improvements to the RSV vaccine.’ Evidently, Merck began its due diligence on the Moderna mRNA platform early...

...The US government gain-of-function moratorium lasted a little over three years. Dr Francis Collins, the Director of the NIH, announced the resumption of research on December 19, 2017, stating it was important ‘in helping us identify, understand, and develop strategies and effective countermeasures against rapidly evolving pathogens that pose a threat to public health’.

What he didn’t admit was that during the moratorium his institute, along with the UC Biomedical Advanced Research and Development Authority (BARDA) and the US military medical countermeasure research programmes, had busied themselves finding ways around the FDA clinical hold by off-shoring development projects for MERS vaccines and synthetic antibody therapeutics."

🦠ANTIBODY DEPENDENT ENHANCEMENT (ADE):

An URGENT health update concerning the potential catastrophic reaction that could be caused by giving Covid vaccinated children the live flu nasal spray - Please read and share widely

Those who have received coronavirus vaccines, could be at risk of a much more severe reaction to live viruses than their unvaccinated counterparts.

"A 2021 study published in the National Library of Medicine concluded:

The specific and significant COVID-19 risk of ADE should have been and should be prominently and independently disclosed to research subjects currently in vaccine trials, as well as those being recruited for the trials and future patients after vaccine approval, in order to meet the medical ethics standard of patient comprehension for informed consent.

This is especially concerning when one considers that secondary school students - many of whom received the COVID-19 vaccines via their schools - are this year being offered, for the first time ever, the flu nasal spray, which contains a variety of live viruses, including a new B-strain which has never been added to the children's nasal spray before.

It is therefore feasible to believe that some of these children's immune systems could dramatically overreact to these viruses as a result of the ADE they may have developed from their Covid vaccines.

ADE is a disorder of the immune system, which effectively renders a person immunodeficient, in that their immune system is not functioning in the normal or optimal way. It is already official medical advice not to give the flu nasal spray to immunodeficient children.

To quote from the University of Oxford:

The nasal flu spray should not be given to anyone who is severely immunodeficient (so that their immune system cannot control viral infections in the normal way)... The resource continues:
"Children who have been vaccinated with the nasal spray should avoid close contact with people who have very severely weakened immune systems (for example, bone marrow transplant patients requiring isolation in a protective environment) for about two weeks following vaccination. If it is not possible for a child to avoid contact with someone who is severely immunosuppressed (for example, because they live in the same house), the child should not receive the nasal flu vaccine.

This means that even children who do not receive the nasal flu vaccine, could be at risk from others in close quarters (such as schoolmates) who do.

There is no data at all to establish that it is safe to give the flu nasal spray to children who have received COVID-19 vaccinations, children who may have developed ADE, and therefore could have a catastrophic reaction to the live viruses contained within the flu spray.

These reactions could be labelled by the government - not as vaccine reactions - but as evidence of "a new variant" that another lockdown is required to contain."

https://www.informedconsentmatters.co.uk/post/vaccine-developers-warned-of-ade-could-it-cause-catastrophe-this-winter

https://twitter.com/robinmonotti/status/1699430541437685788